GlaxoSmithKline (GSK) has appointed Emma Walmsley to the position of chief executive officer (CEO) designate, effective on March 31, 2017 when the current GSK CEO, Andrew Witty, retires. Ms. Walmsley is currently the CEO of GSK’s consumer healthcare division. She will join the GSK board of directors from January 1, 2017.

Prior to her current role, Ms. Walmsley was president of GSK consumer healthcare and has been a member of GSK’s corporate executive team since 2011. She joined GSK in 2010 from L’Oreal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the UK, Europe, and US. From 2007, she was based in Shanghai as general manager, consumer products for L’Oreal China.

Source: GlaxoSmithKline